Post-thrombotic syndrome

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Post-thrombotic syndrome is chronic venous insufficiency that follows DVT in the affected limb. Organised residual thrombus can narrow venous outflow, while inflammation and recanalisation damage valve leaflets and permit reflux. Ambulatory venous pressure remains elevated, especially when the calf-muscle pump is weak. The clinical result ranges from heaviness, aching, cramps, pruritus and dependent swelling to venous ectasia, hyperpigmentation, lipodermatosclerosis and ulceration. Proximal and recurrent ipsilateral DVT, obesity, older age, pre-existing venous disease, persistent obstruction and suboptimal early anticoagulant exposure increase risk, but prediction in an individual remains imperfect.

Diagnosis is clinical and longitudinal. Pain and oedema during the acute DVT episode overlap with PTS, so chronic syndrome should not be declared from an early snapshot. Once acute changes have settled, the Villalta scale provides a reproducible assessment of five symptoms and six signs; a venous ulcer places disease in the severe category. Duplex ultrasound is not a diagnostic score, but it is valuable when symptoms change, recurrence is possible, or significant obstruction and reflux may guide referral. Management aims to reduce symptoms, preserve mobility, protect skin and heal ulcers. Preventive stocking evidence is inconsistent: NICE advises against offering stockings routinely to prevent PTS or VTE recurrence, while allowing symptom-directed use with practical instruction.

Key points

Diagnose PTS from persistent ipsilateral symptoms and signs after the acute DVT phase has settled; do not score transient early swelling as established chronic syndrome.
Use the Villalta scale to combine five symptoms and six clinical signs: a score below 5 indicates no PTS, 5–9 mild, 10–14 moderate, and 15 or more or venous ulcer severe.
New or abruptly worse symptoms require investigation for recurrent DVT, proximal obstruction, infection or arterial disease before attribution to PTS. Do not routinely offer elastic graduated compression stockings to prevent PTS or VTE recurrence; symptom-directed use remains an option with fitting, application, wear-time and replacement advice.
PTS results from chronic venous hypertension caused by residual outflow obstruction, valvular reflux and inflammatory vein-wall damage.
NICE advises against routine elastic graduated compression stockings to prevent PTS or VTE recurrence after DVT.
That prevention recommendation does not prohibit stockings for symptom control; explain fitting, application, wear time, skin care and replacement when offering them.
Exercise, walking, calf-muscle strengthening, weight management, leg elevation and skin care support function and oedema control.
Persistent severe symptoms or ulceration despite conservative care warrants venous specialist assessment for iliocaval obstruction, reflux and selected intervention.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Residual outflow obstruction

Organised thrombus and incomplete recanalisation narrow the deep venous lumen, raising ambulatory pressure distal to the previously thrombosed segment.

Valve injury and reflux

Inflammation, dilatation and thrombus-related damage prevent valve leaflets coapting, allowing retrograde flow and sustaining venous hypertension during standing and walking.

Risk amplifiers

Proximal or recurrent ipsilateral DVT, obesity, older age, pre-existing venous incompetence and inadequate early anticoagulant exposure are associated with greater PTS risk.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Persistent venous hypertension
Outflow resistance and reflux elevate pressure in distal veins and capillaries, particularly during dependency and ineffective calf-muscle pumping.
2
Microvascular inflammation
Capillary hypertension promotes fluid leakage, leukocyte activation and tissue inflammation, producing oedema, aching, dermatitis and progressive skin induration.
3
Tissue remodelling
Chronic inflammation and iron deposition cause hyperpigmentation and lipodermatosclerosis; severe sustained hypertension impairs nutrition and contributes to venous ulceration.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Typical symptom pattern

Heaviness, aching, cramps, pruritus, paraesthesia and swelling worsen with dependency or prolonged standing and often improve with walking, elevation or overnight rest.

Chronic venous signs

Pretibial oedema, venous ectasia, hyperpigmentation, redness, calf tenderness and skin induration in the previously thrombosed limb contribute to the Villalta score.

Timing after acute DVT

Assess persistent findings after the acute inflammatory and oedematous phase, commonly from about three months onward, and follow the pattern over repeated reviews.

Villalta severity

Five symptoms and six signs are each scored 0–3; total 5–9 is mild, 10–14 moderate, and at least 15 or venous ulcer severe.

Acute change is a warningRed flag

Sudden worsening, new cyanosis, severe pain or chest symptoms needs urgent reassessment for recurrent VTE or limb threat rather than automatic rescoring.

Red flags requiring action

Abrupt increase in unilateral swelling or pain after improvement requires objective reassessment for recurrent or propagating DVT.
Cyanosis, massive tense swelling, severe rest pain, neurological change or impaired pulses suggests limb-threatening venous or arterial compromise.
New breathlessness, pleuritic chest pain, syncope or haemoptysis may represent pulmonary embolism rather than a local chronic venous symptom.
Spreading erythema, fever, purulent drainage, rapidly enlarging ulcer or disproportionate pain suggests infection or another urgent complication.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Villalta clinical assessmentFirst step
Why
Diagnose and grade persistent post-thrombotic symptoms and signs systematically.
Interpretation and limitations
Score pain, cramps, heaviness, paraesthesia, pruritus, oedema, pigmentation, ectasia, redness, induration and calf-compression pain; ulceration denotes severe PTS.
02
Duplex venous ultrasound
Why
Exclude recurrent DVT and assess residual obstruction or reflux when clinically relevant.
Interpretation and limitations
Compare with prior imaging because chronic non-compressibility and residual material can persist; a new venous segment or interval extension supports recurrence.
03
Ankle–brachial pressure index or arterial assessment
Why
Identify coexisting arterial disease before substantial compression is prescribed.
Interpretation and limitations
Reduced perfusion changes compression safety and ulcer management; interpret calcified or incompressible vessels with toe pressures or specialist vascular tests.
04
Skin and ulcer assessment
Why
Define severity, infection, exudate, dermatitis and healing barriers.
Interpretation and limitations
Map ulcer size and depth, inspect surrounding skin, pulses and neuropathy; culture only when clinical infection makes the result actionable.
05
Iliocaval cross-sectional imaging
Why
Define proximal outflow obstruction when severe symptoms or intervention are being considered.
Interpretation and limitations
CT or MR venography may show chronic iliac or caval obstruction; invasive venography and intravascular ultrasound are reserved for specialist procedural planning.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Recurrent deep-vein thrombosis

Abrupt new pain or swelling, a new venous segment on ultrasound or interval thrombus extension supports recurrence rather than stable PTS.

Primary venous insufficiency

Bilateral varicosities or symptoms predating DVT suggest superficial or primary deep reflux, which can coexist and contribute to the current phenotype.

Lymphoedema

Foot and toe involvement, skin thickening and less dependency-related fluctuation suggest lymphatic failure, though chronic venous hypertension may cause mixed oedema.

Heart or renal failure

Bilateral oedema with systemic congestion, weight change, dyspnoea or renal abnormalities points toward a systemic cause rather than isolated post-thrombotic disease.

Cellulitis or arterial disease

Warm spreading erythema with systemic upset suggests infection; coolness, reduced pulses, rest pain or tissue loss requires arterial assessment before compression.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Assessment pathwayPersistent symptoms after treated DVTFirst stepIpsilateral pain, heaviness, swelling or skin change persists beyond the acute DVT phase.

1Establish symptom timing and trajectory, examine both legs, calculate a Villalta score and identify sudden change, infection, arterial compromise or cardiopulmonary red flags.
2Use duplex when recurrent DVT or important venous obstruction is possible, comparing previous studies so chronic residual change is not mistaken for acute recurrence.
3Assess arterial supply, mobility, calf-pump function, weight, skin integrity, ulceration and the adequacy and completion of the original VTE treatment.
4Explain the chronic venous mechanism, set symptom and function goals, and arrange follow-up based on severity rather than a single score alone.

02Symptom pathwayRoutine conservative chronic venous managementPTS is mild or moderate without limb threat, acute recurrence or an ulcer requiring a dedicated pathway.

1Explain that elastic graduated compression stockings are not offered routinely to prevent PTS or VTE recurrence, but may be offered for troublesome swelling or discomfort after arterial and skin assessment; give fitting, application, wear-time, replacement and stop-symptom advice.
2Encourage regular walking, progressive calf-muscle strengthening, weight management when relevant, leg elevation and avoidance of prolonged immobility to support the calf pump and function.
3Treat stasis dermatitis with skin protection and appropriate topical care, and address occupational or mobility barriers that worsen dependent venous pressure.
4Review adherence, benefit, skin effects and Villalta pattern; stop or modify compression that is painful, poorly fitted or ineffective.

03Severe pathwayUlceration or disabling venous obstructionVillalta severity is high, a venous ulcer is present, or symptoms remain disabling despite well-delivered conservative care.

1Refer to a vascular or venous specialist service and define deep outflow obstruction, superficial or deep reflux, arterial supply and ulcer characteristics.
2Use a structured ulcer programme with suitable compression, dressings, skin care, nutrition and mobility support after excluding clinically important arterial compromise.
3Discuss selected endovascular recanalisation or stenting only for anatomically significant chronic iliocaval obstruction and after realistic benefit-risk assessment.
4Continue long-term surveillance for stent patency when intervention occurs, ulcer healing, recurrence, functional response and complications.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Venous ulceration

Severe ambulatory venous hypertension damages gaiter-area skin, producing recurrent, exudative ulcers that impair mobility and require sustained compression-based care.

Stasis dermatitis

Inflammation, pruritus and skin-barrier breakdown promote excoriation, sensitisation and secondary infection, particularly when oedema remains poorly controlled.

Functional limitation

Pain, swelling and heaviness reduce walking, work and exercise, which can further weaken the calf pump and worsen long-term quality of life.

Recurrent thrombosis

Previous DVT remains a risk marker for recurrence; new events may compound obstruction and valve damage, increasing PTS severity.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Record serial Villalta components, not just the total, because worsening oedema, skin induration or pain may demand a different investigation than stable pigmentation.
Track limb circumference or oedema pattern, walking tolerance, work and daily function, analgesic need, skin condition and patient-reported benefit from compression.
For venous ulcers measure area and depth at consistent intervals, document exudate and surrounding dermatitis, and escalate when healing stalls or infection appears.
Reassess compression fit, application technique, wear tolerance, skin injury and arterial symptoms; replace worn garments and alter pressure or style when necessary.
At each review ask about sudden leg change and PE symptoms, confirm the anticoagulation plan where still indicated, and avoid extending anticoagulation solely to treat PTS symptoms.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Villalta is a composite

A total score gains meaning from its components and timing. Stable hyperpigmentation plus mild heaviness differs clinically from rapidly increasing pain and oedema with the same arithmetic total.

Prevention and treatment diverge

Evidence does not support prescribing stockings routinely to prevent PTS after every DVT. A patient with established swelling may still obtain worthwhile symptom relief from well-fitted compression.

Ultrasound needs a baseline

Residual venous abnormalities are common after DVT. Comparing the involved segments, compressibility and dimensions with earlier studies improves distinction between chronic change and true recurrence.

Exercise uses the calf pump

Walking and calf strengthening improve venous emptying and counter dependency. Programmes should be graded around pain, frailty, cardiorespiratory reserve and ulcer care rather than prescribing inactivity.

Intervention targets anatomy

Chronic iliocaval recanalisation can help selected patients with severe obstruction, but it is not a general cure for all PTS and requires specialist imaging, antithrombotic planning and surveillance.

11Common pitfallsFrequent interpretation and management errors.

01
Diagnosing PTS during the first days of acute DVT confuses expected inflammatory swelling with chronic venous disease.
02
Attributing sudden recurrent swelling to established PTS without duplex can miss new DVT and renewed embolic risk.
03
Prescribing stockings automatically for prevention contradicts NICE guidance and obscures the separate symptom-relief indication.
04
Applying strong compression without assessing arterial supply, fit, skin integrity and patient dexterity can cause pain, injury and non-adherence.
05
Using anticoagulation longer solely because PTS persists treats neither venous hypertension nor damaged valves and adds bleeding exposure.

Find your next topic